🇺🇸 FDA
Patent

US 9623085

Chimeric natriuretic peptide compositions and methods of preparation

granted A61KA61K38/22A61K38/2242

Quick answer

US patent 9623085 (Chimeric natriuretic peptide compositions and methods of preparation) held by Capricor Therapeutics, Inc. expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Capricor Therapeutics, Inc.
Grant date
Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/22, A61K38/2242, A61K47/02, A61K47/10